China (Mainland)
Premiumsupplier
Anti-cancer drug top quality Everolimus CAS NO.159351-69-6
- Min.Order: 1 Gram
- Payment Terms: T/T,
- Product Details
Keywords
- Everolimus
- Everolimus powder
- cas 159351-69-6
Quick Details
- ProName: Anti-cancer drug top quality Everolimu...
- CasNo: 159351-69-6
- Molecular Formula: C53H83NO14
- Appearance: white powder
- Application: Everolimus may have a role in heart tr...
- DeliveryTime: within 3 working days upon payment
- PackAge: aluminum foil bag, discreet packing
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 1 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: email: wonda-chem@outlook.com
- LimitNum: 1 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
|
Prodcut name |
Everolimus |
|
Synonyms |
SDZRAD; Certican; Zortress; Afinitor; RAD-001;
CERTICAN(R); 42-O-(2-Hydroxyethyl)-rapamycin; Everolimus; Certica;
|
|
MOQ |
1MG |
|
CAS No. |
159351-69-6 |
|
Appearance |
White to off-white powder |
|
Molecular Formula |
C53H83NO14 |
|
Molecular Weight |
958.22 |
|
Assay |
≥98.5% |
|
Application |
Pharma grade or research purpose |
|
Packing |
As per your request |
|
Storage |
Preserve in tight,light-resistant containers in a cool place |
|
Remarks |
NA |
|
Custom synthesis |
Available |
|
Supply Ability |
300g/month |
Function of Everolimus
Everolimus may have a role in heart transplantation, as it has been shown to reduce chronic allograft vasculopathy in such transplants. It also may have a similar role to sirolimus in kidney and other transplants.
Although, sirolimus had generated fears over use of m-TOR inhibitors in liver transplantation recipients, due to possible early hepatic artery thrombosis and graft loss, use of everolimus in the setting of liver transplantation is promising. Jeng et al., in their study of 43 patients, concluded the safety of everolimus in the early phase after living donor liver transplantation. In their study, no hepatic artery thrombosis or wound infection was noted. Also, a possible role of everolimus in reducing the recurrence of hepatocellular carcinoma after liver transplantation was correlated. A target trough level of 3 ng/mL at 3 months was shown to be beneficial in recipients with pre-transplant renal dysfunction. In their study, 6 of 9 renal failure patients showed significant recovery of renal function, whereas 3 showed further deterioration, one of whom required hemodialysis.
Packing and shipping
